Hikma Pharmaceuticals PLC ADR HKMPY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HKMPY is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $47.13
- Day Range
- $46.50–46.50
- 52-Week Range
- $42.23–56.63
- Bid/Ask
- $46.53 / $50.56
- Market Cap
- $5.16 Bil
- Volume/Avg
- 1,570 / 731
Key Statistics
- Price/Earnings (Normalized)
- 10.01
- Price/Sales
- 1.80
- Dividend Yield (Trailing)
- 3.10%
- Dividend Yield (Forward)
- 3.10%
- Total Yield
- 3.10%
Company Profile
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 9,100
- Website
- https://www.hikma.com
Comparables
Valuation
|
Metric
|
HKMPY
|
APH
|
DWF
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.01 | 10.90 | 8.98 |
Price/Book Value | 2.34 | 0.71 | 7.24 |
Price/Sales | 1.80 | 1.12 | 0.85 |
Price/Cash Flow | 11.59 | 8.61 | 6.01 |
Price/Earnings
HKMPY
APH
DWF
Financial Strength
|
Metric
|
HKMPY
|
APH
|
DWF
|
|---|---|---|---|
Quick Ratio | 0.82 | 1.33 | 1.78 |
Current Ratio | 1.57 | 1.93 | 1.93 |
Interest Coverage | 4.75 | 0.31 | 3.39 |
Quick Ratio
HKMPY
APH
DWF
Profitability
|
Metric
|
HKMPY
|
APH
|
DWF
|
|---|---|---|---|
Return on Assets (Normalized) | 10.72% | 3.00% | 9.44% |
Return on Equity (Normalized) | 22.63% | 5.78% | 73.80% |
Return on Invested Capital (Normalized) | 15.78% | 5.22% | 15.38% |
Return on Assets
HKMPY
APH
DWF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Dvmxvfgdg | Vkmgly | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Xlbgqpsmc | Jzmhw | $68.9 Bil | |
HLN
| Haleon PLC ADR | Wspnkwg | Mrfd | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Rxrtltvz | Sgx | $14.8 Bil | |
VTRS
| Viatris Inc | Lvdcpxzy | Kct | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ncltmdfyp | Wqfsk | $11.9 Bil | |
CTLT
| Catalent Inc | Fzsmtlf | Jcdby | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ztrjkggyg | Djth | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Kqlybjzjc | Bsyx | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vdlknpm | Fvdlrnl | $3.5 Bil |